Skip to main content
. 2013 Oct;5(Suppl 5):S524–S539. doi: 10.3978/j.issn.2072-1439.2013.09.06

Table 3. Randomized clinical trials of lung cancer screening using low-dose computed tomography; Target group and screening schedule.

Study Age range Smoking history Participants (baseline), n Screening schedule (years)** Control group Total period of follow up Years of recruitment Completion/expected completion
LDCT arm Control arm Total
NLST, USA (13,81) 55-74 Current or ex-smokers >30 PY, quit <15 yr 26,722 26,732 53,454 0,1,2 CXR 5 2002-4 2009
LSS, USA (pilot study) (82) 55-74 Current or ex-smokers >30 PY, quit <10 yr 1,660 1,658 3,318 0 CXR 1 2000 2001
DANTE, Italy (83) 60-74 (men only) Current or ex-smokers >20 PY 1,276 1,196 2,472 0,1,2,3,4 Annual clinic review 4 2001-6 2010
Dépiscan, France (pilot study) (84) 50-75 Current or ex-smokers >15 PY, quit <15 yr 336 285 765 0,1,2,3 CXR 2 2002-4 2004
NELSON, The Netherlands and Belgium (50,85,86) 50-74 Current or ex-smokers >15 PY, quit <10 yr 7,915 7,907 15,822 0,1,3 Usual care (no intervention) 10 2003-6 2015
DLCST, Denmark (87) 50-70 Current or ex-smokers >20 PY, quit <10 yr 2,052 2,052 4,104 0,1,2,3,4 Usual care (no intervention) 10 2004-6 2014
ITALUNG, Italy (88) 55-69 Current or ex-smokers >20 PY, quit <10 yr 1,613 1,593 3,206 0,1,2,3 Usual care (no intervention) 4 2004-6
MILD, Italy (89) 49-75 Current or ex-smokers >20 PY, quit <10yr 1,190 annual; 1,186 biennial 1,723 4,099 Annual or biennial for 10 years Usual care (no intervention) 10 2005-onwards Ongoing-started 2005
LUSI, Germany (90) 50-69 Current or ex-smokers >15 PY, quit <10yr 2,029 2,023 4,052 0,1,2,3,4 Usual care (no intervention) 5 2007-onwards Ongoing-started 2007
UKLS (pilot study), United Kingdom (91,92) 50-75 5% risk of developing lung cancer in 5 years (Liverpool Lung Project risk model) 2,000* 2,000* 4,000 0 Usual care (no intervention) 10 2011-onwards Ongoing-started 2011

*Planned recruitment; PY, Pack years (cigarettes per day/20× duration of smoking in years); CXR, chest radiograph; **Screening schedule indicates which year the scans are performed with ‘0’ indicating baseline scan; , all participants received CXR + sputum cytology at baseline.